Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by David Orlicky and Thomas Flaig.

 
Connection Strength
  
 
 
0.436
  
  1. Graham LS, Su LJ, Nicklawsky A, Feng FX, Orlicky D, Petraccione J, Salzmann-Sullivan M, Nordeen SK, Flaig TW. Cell Models of Castration Resistant and High Dose Testosterone-Resistant Prostate Cancer Recapitulate the Heterogeneity of Response Observed in Clinical Practice. Cancers (Basel). 2025 Feb 10; 17(4).
    View in: PubMed
    Score: 0.244
  2. Nordeen SK, Su LJ, Osborne GA, Hayman PM, Orlicky DJ, Wessells VM, van Bokhoven A, Flaig TW. Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer. Life (Basel). 2021 Aug 27; 11(9).
    View in: PubMed
    Score: 0.192
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)